Loading...

Private & Confidential — Transcend
← Back to Guides

Portfolio Analysis Process

Choose the right analysis path, assemble the source packet, and hand off a decision-ready output without duplicating specialist methods.

Portfolio Analysis Spine Version 2.0 Reviewed: May 20, 2026

Executive Summary

Start every portfolio analysis by naming the decision: product quality, marketing allocation, KPI monitoring, experiment reliability, or company intelligence. Each decision has a different source floor, method owner, and output. This page is the router; the specialist guides own the math, diagnostics, and deep execution.

Primary Users Transcend portfolio team, portfolio founders, operators, and analysts preparing support work.
Also Allowed Approved guide-access users learning how Transcend separates analysis questions.
Not Here Raw exports, company incidents, LP data, private model outputs, or investment recommendations.
Source Freshness

Reviewed May 20, 2026 against the local ROAS Analysis Pipeline, Company Analysis Standard v1.1.0, and portfolio diagnostic template. The ROAS methodology file contains future-dated metadata; this page treats it as a local methodology reference only and does not surface that date as a current factual claim.

1. Decision Router

The first choice is the analysis track. Do not blend tracks just because they share data. Blended questions create blended recommendations and make it impossible to know which method should be trusted.

TrackQuestion It AnswersMinimum Source FloorOutputSpecialist Owner
Product ReviewIs the product improving or degrading after releases?Version history, isolated cohort data, product change notes.Product quality read, release impact, open confounds.ROAS pipeline + product-marketing analysis.
Marketing AllocationWhere should we scale, pause, or investigate spend?All-geo/all-network MMP export, revenue definition, platform fees.Kill/scale recommendations and budget implications.ROAS analytics and marketing report.
KPI MonitoringDid a metric move enough to require action?Stable metric series, baseline window, known release/events calendar.Alert, watch, or no-action status.Control chart diagnostics.
Experiment ReadIs the test result reliable enough to decide?Hypothesis, variants, sample size, guardrails, duration.Scale, stop, extend, or redesign decision.Statistical significance guide.
Company DiagnosticWhat do we know, what changed, and what can we do with it?PROFILE, Affinity notes, diagnostic findings, company data sources.Forward-looking diagnostic findings and next support actions.Company Analysis Standard + diagnostic template.

Default split

If the user asks...Route to...Reason
"Is the game better?"Product ReviewNeeds isolated product signal, not blended channel mix.
"Where should we spend?"Marketing AllocationNeeds full market/channel view and revenue economics.
"Is this drop real?"KPI MonitoringNeeds process-control thinking before diagnosis.
"Did the test win?"Experiment ReadNeeds power, confidence, and guardrail checks.
"What is the portfolio support plan?"Company DiagnosticNeeds source-backed synthesis and opportunity framing.

2. Source Packet Before Analysis

No analysis starts until the source packet is explicit. For company-specific work, read local company docs and check Affinity before touching files or writing recommendations.

Source ClassRequired ForWhat It Must AnswerBlocker If Missing
Company contextAll company-specific analysis.Company status, GP owner, product, data sources, known confounds, Affinity history.Analysis cannot start.
Data manifestMMP, ROAS, retention, and KPI work.Source system, extraction date, revenue type, timezone, platform fee treatment.No projection or budget recommendation.
Version historyProduct review and regime attribution.Release dates, hotfixes, status, expected impact, known bugs.No version-impact claim.
Event calendarKPI monitoring and diagnostics.Launches, campaigns, pricing changes, outages, creative refreshes.No causal explanation.
Review ownerExternal or founder-facing output.Who approves facts, tone, recommendations, and open questions.No send/share.

Security Gate

Raw exports and private company metrics stay inside the authorized company or analysis workspace. Public guide pages can explain methods, but they should not embed company-specific incidents, raw exports, private LP/fund metrics, or CRM notes.

3. Five-Step Operating Process

StepActionPass StandardCommon Failure
1. IntakeName the decision, audience, source owner, and deadline.One decision sentence under 20 words.Starting with a file dump.
2. ValidateCheck schema, completeness, revenue definition, and obvious data bugs.Known gaps are documented before analysis.Projecting from broken or mixed data.
3. IsolateChoose the cut that matches the question: product, channel, geo, platform, cohort, or time window.Confounds are either controlled or named.Blending product and marketing signals.
4. AnalyzeRun the specialist method and preserve assumptions.Output includes method, source, confidence, and limitations.Producing a number without a decision implication.
5. DocumentWrite the finding, opportunity, next action, and unresolved questions.Every insight answers "what can we do with this?"Leaving insight only in a chat thread.

4. Output and Handoff Rules

The output format should match the decision and audience. A founder-facing diagnostic, an internal investment dossier, and a raw analytics run should not collapse into the same document.

OutputAudienceCanonical RoleNext Route
Product ReviewFounder, product lead, Transcend advisor.Explain whether product changes improved quality or monetization.Product-marketing analysis or ROAS diagnostic.
Marketing ReportFounder, UA lead, Transcend advisor.Translate cohort economics into spend decisions.ROAS analytics or experimentation system.
Diagnostic FindingsPortfolio company team and GP owner.Capture what changed, why it matters, and what support action follows.Company folder diagnostic record.
Company AnalysisInvestment or strategy team.Maintain verified intelligence and evaluative context.Investment assessment or strategic memo.
Open QuestionsData owner or founder.State missing data and why it blocks interpretation.Follow-up request in the same channel.

5. MECE Boundary With Specialist Guides

This Page OwnsSpecialist Page OwnsBoundary
Choosing the analysis track.Product-Marketing AnalysisProduct-marketing owns state-machine diagnosis and funnel interpretation.
Requiring a source packet.ROAS DiagnosticROAS owns metric decomposition and root-cause workflow.
Routing noise vs action questions.Control Chart DiagnosticsControl charts own monitoring thresholds and special-cause logic.
Routing experiment questions.Statistical SignificanceStats owns power, confidence, sample size, and test interpretation.
Document handoff discipline.Company Analysis StandardCompany analysis owns dossier structure and verified intelligence.

6. Internal Source References

These local references are the source floor for this router. Do not cite them as external evidence; use them to choose the right internal workflow and artifact owner.

ReferenceUse in This Guide
skills/skills/ROAS_ANALYSIS_PIPELINE.mdROAS stages, source manifest, producer/consumer boundaries, and methodology ownership.
investment-assessment/COMPANY_ANALYSIS_STANDARD.mdMECE split between PROFILE, Company Analysis, and Investment Assessment.
skills/skills/portfolio-diagnostic/templates/DIAGNOSTIC_FINDINGS_TEMPLATE.mdForward-looking diagnostic findings and "what can we do with this?" framing.
guides/product-marketing-analysis/, guides/roas-diagnostic/, guides/control-chart-diagnostics/, guides/statistical-significance/Specialist pages that own methods after this router chooses the track.
✍️ Select text to comment
➕ Add Comment

💬 Comments

💬

No comments yet.

Select text to add the first comment.

Add Comment